Approved for DIACOMIT is indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients taking clobazam who are 6 months of age and older and weighing 7 kg or more. There are no clinical data to support the use of DIACOMIT as monotherapy in Dravet syndrome.. The mechanism by which DIACOMIT exerts its anticonvulsant effect in humans is unknown. Possible mechanisms of…
Loading full data from Know Your Drugs Institute…